Education
About Us
Working with TipRanks
Follow Us
Memphasys Ltd (AU:MEM)
ASX:MEM
MEM Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.01
Previous CloseN/A
Volume7.30M
Average Volume (3M)17.19M
Market Cap
AU$10.46M
Enterprise ValueAU$12.84M
Total Cash (Recent Filing)AU$298.30K
Total Debt (Recent Filing)AU$5.11M
Price to Earnings (P/E)―
Beta-0.52
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,614,614,500
10 Day Avg. Volume17,186,563
30 Day Avg. Volume17,186,563
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)2.50
Price to Sales (P/S)25.46
P/FCF Ratio-5.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Memphasys Ltd News
MEM FAQ
What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is Memphasys Ltd’s market cap?
Memphasys Ltd’s market cap is AU$10.46M.
When is Memphasys Ltd’s upcoming earnings report date?
Memphasys Ltd’s upcoming earnings report date is Feb 20, 2026 which is in 66 days.
How were Memphasys Ltd’s earnings last quarter?
Memphasys Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Memphasys Ltd overvalued?
According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued.
Does Memphasys Ltd pay dividends?
Memphasys Ltd does not currently pay dividends.
What is Memphasys Ltd’s EPS estimate?
Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Memphasys Ltd have?
Memphasys Ltd has 2,614,614,500 shares outstanding.
What happened to Memphasys Ltd’s price movement after its last earnings report?
Memphasys Ltd reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Memphasys Ltd?
Currently, no hedge funds are holding shares in AU:MEM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Memphasys Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:MEM Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-90.15%
Trailing 12-Months
Asset Growth
-9.80%
Trailing 12-Months
Company Description
Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.
Living Cell Technologies
―
Regeneus Ltd.
―
Avecho Biotechnology Limited
―
AdAlta Ltd.
―
Chimeric Therapeutics Ltd.
―